Navigation Links
Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing
Date:2/23/2010

ROCKVILLE, Md., Feb. 23 /PRNewswire/ -- STB Lifesaving Technologies® announced today $2.4 million was included in the FY2010 U.S. Department of Defense appropriations bill to advance the development of the Fibrin Adhesive STat (FAST®) dressing. This newly developed dressing is designed to be effective against all kinds of blood loss, including severe arterial and venous bleeding and could help save the lives of soldiers suffering from severe blood loss.

According to the Combat Casualty Care Research Program, eighty-six percent of combat-related deaths occur within 30 minutes of wounding, and fifty percent or more are attributable to uncontrolled hemorrhaging.  With better products to control bleeding, such as the STB FAST® dressing, thousands of military and civilian lives could be saved.

"We are grateful for Senator Cardin's continued support for STB® and honored by the opportunity to serve the Department of Defense. If awarded to STB®, these funds, along with funds provided by our investors, will be used to accelerate the step up to cGMP manufacturing, and the necessary planning and pre-clinical work required to file for approval by the FDA to initiate human clinical trials," said Ron Peele, STB®'s President.  

Much of the clinical planning will involve advisors from the University of Maryland and MD Shock Trauma Center, who will also be involved in the in vivo efficacy testing, which will be conducted at a facility in Reisterstown, MD.

About STB®  

Founded in 2005, STB Lifesaving Technologies® (STB®) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland. STB® which stands for "stop the bleeding", is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural protein technology with five patents and one provisional patent pending, STB®'s products will be indispensable to both the military and civilian medical markets.

SOURCE STB Lifesaving Technologies

Back to top

RELATED LINKS
http://www.stblifesaving.com

'/>"/>

SOURCE STB Lifesaving Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
3. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
4. Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications
5. U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain
6. Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan
7. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
8. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
9. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
10. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
11. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016 /PRNewswire/ ... a synergistic confluence of various technologies that ... propositions, previously unavailable. These opportunities create a ... convergence, in turn, drives the development of ... scenario is characterized by technology convergences, which ...
(Date:2/10/2016)... 2016 Mast Therapeutics, Inc. (NYSE ... for sickle cell disease and heart failure, today announced ... units at a price to the public of $0.275 ... the Company,s common stock and one warrant to purchase ... exercise price of $0.42 per share. The warrants are ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... Compliancy Group LLC is pleased to offer ... the country. The Guard was specifically designed to handle each element required for ... updates, and compliance coaching. , In addition to meeting the compliance needs of ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize ... can leave patients with dental emergencies at risk of losing a tooth or their ... care. , Common dental emergencies include:, , Avulsed or ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... Indianapolis, IN (PRWEB) , ... February 10, 2016 ... ... employee benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its ... and has seven other locations throughout the Southeast, from Orlando to Huntsville and ...
Breaking Medicine News(10 mins):